Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Other Working Capital Changes (2022 - 2025)

Historic Other Working Capital Changes for Envoy Medical (COCH) over the last 4 years, with Q3 2025 value amounting to $118000.0.

  • Envoy Medical's Other Working Capital Changes rose 22901.16% to $118000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $480000.0, marking a year-over-year increase of 123835.22%. This contributed to the annual value of -$145000.0 for FY2024, which is 11699.88% down from last year.
  • Latest data reveals that Envoy Medical reported Other Working Capital Changes of $118000.0 as of Q3 2025, which was up 22901.16% from -$119000.0 recorded in Q2 2025.
  • Over the past 5 years, Envoy Medical's Other Working Capital Changes peaked at $703000.0 during Q3 2023, and registered a low of -$459000.0 during Q4 2022.
  • In the last 4 years, Envoy Medical's Other Working Capital Changes had a median value of $35865.0 in 2024 and averaged $62324.3.
  • Per our database at Business Quant, Envoy Medical's Other Working Capital Changes soared by 539605.19% in 2023 and then tumbled by 49666.67% in 2025.
  • Over the past 4 years, Envoy Medical's Other Working Capital Changes (Quarter) stood at -$459000.0 in 2022, then skyrocketed by 96.73% to -$15000.0 in 2023, then surged by 2806.67% to $406000.0 in 2024, then plummeted by 70.94% to $118000.0 in 2025.
  • Its Other Working Capital Changes was $118000.0 in Q3 2025, compared to -$119000.0 in Q2 2025 and $75000.0 in Q1 2025.